Sunil Healthcare Ltd. Announces Mixed Q1 FY27 Results, Schedules AGM

Standalone Profit After Tax: Rs. 51.06 Lakh
Consolidated Profit After Tax: Rs. 46.31 Lakh

Reader Takeaway: Standalone profit up amid revenue dip; consolidated profit faces pressure. AGM on Sept 28.

What just happened

Sunil Healthcare Ltd. announced its financial results for the first quarter of fiscal year 2026-27 (Q1 FY27) on August 13, 2026. On a standalone basis, the company reported a Profit After Tax (PAT) of Rs. 51.06 lakh, an increase from Rs. 28.62 lakh in Q1 FY26. However, consolidated PAT decreased to Rs. 46.31 lakh from Rs. 90.78 lakh in the same period last year. Revenue from operations saw a decline on both standalone and consolidated fronts.

The company also announced that its 52nd Annual General Meeting (AGM) will be held on September 28, 2026, through Video Conferencing/Other Audio Visual Method (VC/OAVM).

Why this matters

The mixed financial performance indicates potential challenges in integrating or managing overseas operations, as foreign subsidiaries showed a net loss. The decline in revenue, despite the rise in standalone profit, suggests cost management efforts or other income sources bolstered the standalone bottom line. The upcoming AGM is a crucial event for shareholders to understand management's strategy and future outlook.

The backstory

In the previous year's comparable quarter (Q1 FY26), Sunil Healthcare had reported a higher consolidated PAT of Rs. 90.78 lakh. The company's foreign subsidiaries, Sunil Healthcare Mexico Sa De CV and Sunil Healthcare North America LLC, have historically been non-material to the group's overall financials. An accounting update involved remeasuring deferred tax liability related to leasehold land under Section 200 of the Income Tax Act, 2025.

What changes now

Shareholders will be looking for clarity on the factors affecting the consolidated performance and the revenue dip. The company's decision to exercise the option under the Income Tax Act may have a one-time impact on the reported financials. The focus will shift towards the company's plans for the upcoming fiscal year and the performance of its domestic operations.

Risks to watch

The decline in consolidated PAT and revenue from operations warrants attention. The performance and financial contribution of foreign subsidiaries, even if non-material, could become a point of concern if losses widen. The company also faces the inherent risks associated with market fluctuations and operational efficiency.

Peer comparison

(No peer comparison data available in the filing.)

Context metrics (time-bound)

• Q1 FY27 Standalone Revenue: Rs. 1,898.59 lakh
• Q1 FY26 Standalone Revenue: Rs. 2,264.20 lakh
• Q1 FY27 Standalone PAT: Rs. 51.06 lakh
• Q1 FY26 Standalone PAT: Rs. 28.62 lakh
• Q1 FY27 Consolidated PAT: Rs. 46.31 lakh
• Q1 FY26 Consolidated PAT: Rs. 90.78 lakh
• AGM Date: September 28, 2026
• Book Closure: September 22-28, 2026

What to track next

Investors should track the company's commentary on the revenue decline and consolidated performance during the AGM. Monitoring the performance of foreign subsidiaries and any further accounting adjustments will also be important.